Cramer Gives His Opinion On Service Corporation, Vertex And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ: INSG) acts.

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said he isn’t happy with the way Inseego Corp (NASDAQ:INSG) acts. He is beginning to believe it deserves to be trading 45% lower.

Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) is instrumental, said Cramer. He likes its drug Nurtec.

Cramer is not a buyer of Service Corporation International (NYSE:SCI). He said there are ways to make COVID-19 less life-threatening than the last year.

Cramer is astonished at how much Vertex Pharmaceuticals (NASDAQ:VRTX) has fallen given its cystic fibrosis franchise. He wouldn’t sell it at its current price.

Total
0
Shares
Related Posts
Read More

Tesla’s AI Day Round The Corner, Ford Shuffles Around Team With Eye On EV Leadership, GM Says Hummer All-Electric Reservations Fully Booked: Week’s Biggest EV Stories

Electric vehicle stocks fell across the board in the week ending Sept. 23, dragged by the Fed-induced sell-off in the market. Stung by worries concerning a potential recession and the impact of a rising rate environment, most clocked double-digit losses. Now, here are the key events that happened in the EV space during the week:

F